|
| Exchange Disseminated Time 04/05/2018 19:30:20 | Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company is scheduled to be held on May 17, 2018, inter alia, to consider and transact the following businesses:
1. To consider & approve inter alia, the Audited Standalone and Consolidated Financial Results of the Company for the year ended March 31, 2018;
2. To recommend declaration of dividend for the financial year ended March 31, 2018, if any.
Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company will be closed from May 14, 2018 to May 21, 2018 (both days inclusive). |
|
|